Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey

Basit Öğe Kaydı
dc.contributor.authorKilickap, S.
dc.contributor.authorDemirci, U.
dc.contributor.authorBugdayci, F.
dc.contributor.authorTural, D.
dc.contributor.authorKorkmaz, T.
dc.contributor.authorPaydas, S.
dc.contributor.authorYilmaz, C.
dc.date.accessioned2024-04-24T16:15:23Z
dc.date.available2024-04-24T16:15:23Z
dc.date.issued2019
dc.departmentDicle Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.1016/j.jtho.2019.08.1166
dc.identifier.endpageS559en_US
dc.identifier.issn1556-0864
dc.identifier.issn1556-1380
dc.identifier.issue10en_US
dc.identifier.startpageS558en_US
dc.identifier.urihttps://doi.org/10.1016/j.jtho.2019.08.1166
dc.identifier.urihttps://hdl.handle.net/11468/15784
dc.identifier.volume14en_US
dc.identifier.wosWOS:000492162203082
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofJournal of Thoracic Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAlk Positiveen_US
dc.subjectRos1 Positiveen_US
dc.subjectLorlatiniben_US
dc.subjectAdvanced Stage Lung Canceren_US
dc.titleLorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkeyen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu